Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 135, 141-146
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)Radiotherapy and Oncology, 2014
- Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancerEuropean Journal of Cancer, 2012
- The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancerRadiotherapy and Oncology, 2012
- Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialThe Lancet Oncology, 2012
- Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based studyRadiotherapy and Oncology, 2012
- Intensity-Modulated Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer: A Dose-Escalation Planning StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Radiation Dose–Volume Effects in the LungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patientsAnnals of Oncology, 2007